MoreMore

While National Migraine and Headache Awareness Month (MHAM) wrapped up in June, U.S. Pain Foundation is continuing to raise awareness through its traveling display of the INvisible Project: Migraine second edition. Below is a photo recap of June and the ongoing efforts to bring about change for people living with headache and migraine disease.

End of May
The INvisible Project: Migraine second edition was released in time for MHAM.

Read More

It’s National Migraine and Headache Awareness Month (MHAM), and we have a number of exciting developments to kick it off, as well as numerous ways to participate. Be sure to follow U.S. Pain on Facebook and Twitter to stay up to date on the latest news, events, and ways to get involved.

First-ever migraine prevention drug approved

On May 17, the Food and Drug Administration (FDA) approved the first-ever migraine preventive drug. Often referred to as a CGRP (calcitonin gene-related peptide) or CGRP inhibitor, the drug blocks the CGRP receptor that is believed to play a role in migraine.

Read More

U.S. Pain Foundation is teaming up with Coalition For Headache And Migraine Patients (CHAMP) for National Migraine & Headache Awareness Month (MHAM) this June. If interested in taking part, please respond quickly to ensure your efforts are completed in June.

Here are three ways you can get involved:

MHAM Proclamation: Submit a request for a ceremonial proclamation from your state or local representatives. We’ll provide the template, instructions and support. Interested? Send an email to mham@uspainfoundation.org for more details and please include the state in which you live. Thanks to Ambassador Jeannette Rotondi for her work on this project.

Read More